ヒストソニックスは2009年に設立され、2023年10月にFDAのDe Novo承認を取得しており、細胞内レベルで、かつ従来の手技における侵襲性や毒性なしに、標的組織や腫瘍の機械的な破壊・液化のため、非侵襲的な焦点超音波エネルギーを活用しています。

HistoSonics, founded in 2009, received FDA De Novo clearance in October 2023 and uses non-invasive focused ultrasound energy to mechanically destroy and liquify targeted tissue and tumors at a ...

Megaport Limited (ASX : MP1) (« Megaport »), le premier fournisseur mondial de réseau en tant que service (Network as a ...

Guitar Center Launches First-Ever In-Store AI Shopping Assistant in Music Retail, Transforming How Musicians Discover Gear.

Comvest Credit Partners (“Comvest”), a leading middle market direct lending private credit manager with $14.7 billion of ...

Graymont and Fortera announced they have signed a strategic partnership agreement providing the framework to produce ...

Graymont y Fortera anunciaron la firma de un acuerdo de asociación estratégica mediante el cual se proporciona el marco para ...

A Bentley Systems, Incorporated (Nasdaq: BSY), empresa de software de engenharia de infraestrutura, anunciou hoje os ...

BEYOND Developments, het vooruitstrevende vastgoedmerk dat lifestylebestemmingen aan zee vormgeeft, heeft PASSO onthuld, een ...

DHI Group, Inc. (NYSE: DHX) today announced it has acquired AgileATS, a leading applicant tracking system (ATS) purpose-built ...

Bentley Systems, Incorporated (Nasdaq: BSY), firma zajmująca się oprogramowaniem do inżynierii infrastruktury, ogłosiła ...

Bentley Systems, Incorporated (Nasdaq : BSY), éditeur de logiciels d'ingénierie dédiés aux infrastructures, a annoncé aujourd ...